Supha Pharmachem Limited has announced the relocation of its registered office within Mumbai, moving from its current location in Marol to a new address in Goregaon East. The board of directors approved this significant corporate change during their meeting held on March 17, 2026.

Board Approval and Timeline

The company's board of directors considered and approved the shifting of the registered office during their meeting on Tuesday, March 17, 2026. The relocation takes effect immediately from the same date, demonstrating swift implementation of the board's decision.

Office Relocation Details

The registered office transition involves a complete change of location within Mumbai:

Regulatory Compliance

Supha Pharmachem Limited has duly informed BSE Limited about this corporate development under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Whole Time Director Adarsh Munjal, who holds DIN 07304004.

Company Background

The company, formerly known as Remedium Lifecare Limited, operates under CIN L24100MH1988PLC343805. The registered office relocation represents a strategic move within Mumbai's business landscape, transitioning from the Marol Industrial Estate area to the Express Zone Mall complex in Goregaon East.

This administrative change ensures continued compliance with regulatory requirements while potentially providing enhanced operational facilities at the new location. The company maintains its commitment to transparency by promptly notifying stakeholders and regulatory authorities about this corporate development.

Remedium Lifecare Limited has officially completed its transformation to Supha Pharmachem Limited following approval from the Ministry of Corporate Affairs. The pharmaceutical company, which specializes in Active Pharmaceutical Ingredients (APIs) and intermediates, received the Certificate of Incorporation pursuant to change of name on December 15, 2025.

Official Name Change Approval

The Office of the Central Processing Centre, Ministry of Corporate Affairs, issued the Certificate of Incorporation pursuant to change of name on December 15, 2025. The company has been officially renamed from Remedium Lifecare Limited to Supha Pharmachem Limited with effect from December 15, 2025.

Shareholder Approval Background

Prior to the official approval, shareholders had overwhelmingly supported the name change through a postal ballot, with over 97.00% approval. The special resolution was part of three key resolutions that also included important board appointments.

New Board Leadership

Alongside the name change, the company confirmed two significant board appointments:

Executive Leadership

Mr. Vignesh Laxman Gawde was appointed as Executive Director for a five-year term. Mr. Gawde holds an M.Sc. in Physical Chemistry from the Institute of Science, Mumbai University.

Board Chairman

Mr. Rambhajan Vishwakarma was appointed as Non-Executive Director and Chairman of the Board, bringing over 15 years of experience in banking product sales.

Implementation and Next Steps

The company has informed BSE Limited about the official name change and will process the necessary applications with the stock exchange. All company records and documents will be updated to reflect the new name - Supha Pharmachem Limited. As per regulatory requirements, the company must display both the old and new names at all required locations for a period of two years.

Corporate Details

The successful completion of the name change to Supha Pharmachem Limited represents a significant milestone in the company's evolution, potentially signaling a new strategic direction in the pharmaceutical industry.